Effects of the SGLT2 Inhibitor Dapagliflozin on Proteinuria in Non-Diabetic Patients with Chronic Kidney Disease (DIAMOND): A Randomised Double Blind Cross-Over Trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.